NCT01140412 - Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Healthy

Interventions

DRUG

Maraviroc

maraviroc 300 mg BID x 5 days

DRUG

Fosamprenavir/ritonavir

fosamprenavir/ritonavir 700/100 mg BID x 10 days

DRUG

Maraviroc + Fosamprenavir/ritonavir

maraviroc 300 mg BID + fosamprenavir/ritonavir 700/100 mg BID x 10 days

DRUG

Maraviroc

maraviroc 300 mg QD x 5 days

DRUG

Fosamprenavir/ritonavir

fosamprenavir/ritonavir 1400/100 mg QD x 10 days

DRUG

Maraviroc + Fosamprenavir/ritonavir

maraviroc 300 mg QD + fosamprenavir/ritonavir 1400/100 mg QD x 10 days

Trial Locations (1)

Pfizer Investigational Site, Singapore